Expectancy effects, encompassing both placebo and nocebo phenomena, are gaining increasing recognition across medical disciplines, including gastroenterology.1 Understanding psychological influences ...

About the HURCULES Study HURCULES—a study name that combines the target indication HURler syndrome and HerCULES, the classical mythological character—is a multi-center, randomized, active controlled ...

TMCnet News Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome [July 07, 2025] ...

Girls and women with Turner syndrome face a lifelong struggle with both congenital heart disease and acquired cardiovascular conditions. Bicuspid aortic valve is common, and many have left-sided heart ...

About the HURCULES Study HURCULES—a study name that combines the target indication HURler syndrome and HerCULES, the classical mythological character—is a multi-center, randomized, active controlled ...

TOKYO and LONDON and BOSTON, July 07, 2025 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a Kyowa Kirin company, today announced the last patient has been treated in a registrational trial evaluating the ...

Orchard Therapeutics, a Kyowa Kirin company, today announced the last patient has been treated in a registrational trial evaluating the efficacy and safety of OTL-203, an investigational hematopoietic ...

Early in the 2025 MLB season, the Milwaukee Brewers saw their starting rotation suffer a plethora of injuries that landed just about everyone on the injured list.

Approximately 60 percent of children born with MPS-I have the most severe subtype, MPS-IH, also called Hurler syndrome, and rarely live past the age of 10 when untreated.

Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome Provided by GlobeNewswire Jul 7, 2025, 4:00:11 AM ...

A Milwaukee Brewers right-hander who has battled back from Tommy John surgery might sadly become the victim of a necessary roster move.